Dysregulated Phosphoinositide 3-kinase Signaling in Microglia: Shaping Chronic Neuroinflammation

Overview

Journal J Neuroinflammation

Publisher Biomed Central

Date 2021 Nov 28

PMID 34838047

Citations 40

Authors

Erskine Chu

Richelle Mychasiuk

Margaret L Hibbs

Bridgette D Semple

Affiliations

Soon will be listed here.

Abstract

Microglia are integral mediators of innate immunity within the mammalian central nervous system. Typical microglial responses are transient, intending to restore homeostasis by orchestrating the removal of pathogens and debris and the regeneration of damaged neurons. However, prolonged and persistent microglial activation can drive chronic neuroinflammation and is associated with neurodegenerative disease. Recent evidence has revealed that abnormalities in microglial signaling pathways involving phosphatidylinositol 3-kinase (PI3K) and protein kinase B (AKT) may contribute to altered microglial activity and exacerbated neuroimmune responses. In this scoping review, the known and suspected roles of PI3K-AKT signaling in microglia, both during health and pathological states, will be examined, and the key microglial receptors that induce PI3K-AKT signaling in microglia will be described. Since aberrant signaling is correlated with neurodegenerative disease onset, the relationship between maladapted PI3K-AKT signaling and the development of neurodegenerative disease will also be explored. Finally, studies in which microglial PI3K-AKT signaling has been modulated will be highlighted, as this may prove to be a promising therapeutic approach for the future treatment of a range of neuroinflammatory conditions.

Citing Articles

Neurodegenerative diseases and neuroinflammation-induced apoptosis.

Huang S, Lu Y, Fang W, Huang Y, Li Q, Xu Z Open Life Sci. 2025; 20(1):20221051.

PMID: 40026360 PMC: 11868719. DOI: 10.1515/biol-2022-1051.

Microglia aggregates define distinct immune and neurodegenerative niches in Alzheimer's disease hippocampus.

Fixemer S, Miranda de la Maza M, Hammer G, Jeannelle F, Schreiner S, Gerardy J Acta Neuropathol. 2025; 149(1):19.

PMID: 39954093 PMC: 11829914. DOI: 10.1007/s00401-025-02857-8.

Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer's Disease.

Lee E, Chang Y Cells. 2025; 14(3).

PMID: 39936960 PMC: 11817173. DOI: 10.3390/cells14030168.

Exploring the comorbidity mechanisms between atherosclerosis and hashimoto's thyroiditis based on microarray and single-cell sequencing analysis.

Ma Y, Wu S, Lai J, Wan Q, Hu J, Liu Y Sci Rep. 2025; 15(1):1792.

PMID: 39805933 PMC: 11730997. DOI: 10.1038/s41598-025-85112-0.

Report of the Italian Cohort with Activated Phosphoinositide 3-Kinase δ Syndrome in the Target Therapy Era.

Barzaghi F, Moratti M, Panza G, Rivalta B, Giardino G, De Rosa A J Clin Immunol. 2024; 45(1):58.

PMID: 39714594 PMC: 11666751. DOI: 10.1007/s10875-024-01835-1.

References

Xie S, Chen M, Yan B, He X, Chen X, Li D . Identification of a role for the PI3K/AKT/mTOR signaling pathway in innate immune cells. PLoS One. 2014; 9(4):e94496. PMC: 3981814. DOI: 10.1371/journal.pone.0094496. View

Febinger H, Thomasy H, Pavlova M, Ringgold K, Barf P, George A . Time-dependent effects of CX3CR1 in a mouse model of mild traumatic brain injury. J Neuroinflammation. 2015; 12:154. PMC: 4557842. DOI: 10.1186/s12974-015-0386-5. View

Griffith C, Eid T, Rose G, Patrylo P . Evidence for altered insulin receptor signaling in Alzheimer's disease. Neuropharmacology. 2018; 136(Pt B):202-215. DOI: 10.1016/j.neuropharm.2018.01.008. View

Lively S, Schlichter L . Microglia Responses to Pro-inflammatory Stimuli (LPS, IFNγ+TNFα) and Reprogramming by Resolving Cytokines (IL-4, IL-10). Front Cell Neurosci. 2018; 12:215. PMC: 6066613. DOI: 10.3389/fncel.2018.00215. View

Li Q, Cheng Z, Zhou L, Darmanis S, Neff N, Okamoto J . Developmental Heterogeneity of Microglia and Brain Myeloid Cells Revealed by Deep Single-Cell RNA Sequencing. Neuron. 2019; 101(2):207-223.e10. PMC: 6336504. DOI: 10.1016/j.neuron.2018.12.006. View

Erener S, Petrilli V, Kassner I, Minotti R, Castillo R, Santoro R . Inflammasome-activated caspase 7 cleaves PARP1 to enhance the expression of a subset of NF-κB target genes. Mol Cell. 2012; 46(2):200-11. DOI: 10.1016/j.molcel.2012.02.016. View

Koo J, Jang Y, Hwang D, Um H, Lee N, Jung J . Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-κB signaling pathway. Neuroscience. 2017; 356:102-113. DOI: 10.1016/j.neuroscience.2017.05.016. View

Barodia S, McMeekin L, Creed R, Quinones E, Cowell R, Goldberg M . PINK1 phosphorylates ubiquitin predominantly in astrocytes. NPJ Parkinsons Dis. 2019; 5:29. PMC: 6906478. DOI: 10.1038/s41531-019-0101-9. View

Kim C, Nakamura M, Hsieh C . Brain trauma elicits non-canonical macrophage activation states. J Neuroinflammation. 2016; 13(1):117. PMC: 4879757. DOI: 10.1186/s12974-016-0581-z. View

10.

Gabbouj S, Ryhanen S, Marttinen M, Wittrahm R, Takalo M, Kemppainen S . Altered Insulin Signaling in Alzheimer's Disease Brain - Special Emphasis on PI3K-Akt Pathway. Front Neurosci. 2019; 13:629. PMC: 6591470. DOI: 10.3389/fnins.2019.00629. View

11.

Kim J, Byun J, Choi I, Kim B, Jeong H, Jou I . PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices. Exp Neurobiol. 2013; 22(1):38-44. PMC: 3620457. DOI: 10.5607/en.2013.22.1.38. View

12.

Weekman E, Sudduth T, Abner E, Popa G, Mendenhall M, Brothers H . Transition from an M1 to a mixed neuroinflammatory phenotype increases amyloid deposition in APP/PS1 transgenic mice. J Neuroinflammation. 2014; 11:127. PMC: 4128532. DOI: 10.1186/1742-2094-11-127. View

13.

Erblich B, Zhu L, Etgen A, Dobrenis K, Pollard J . Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits. PLoS One. 2011; 6(10):e26317. PMC: 3203114. DOI: 10.1371/journal.pone.0026317. View

14.

Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland T . A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease. Cell. 2017; 169(7):1276-1290.e17. DOI: 10.1016/j.cell.2017.05.018. View

15.

Tan Y, Yuan Y, Tian L . Microglial regional heterogeneity and its role in the brain. Mol Psychiatry. 2019; 25(2):351-367. PMC: 6974435. DOI: 10.1038/s41380-019-0609-8. View

16.

Konishi H, Kiyama H . Microglial TREM2/DAP12 Signaling: A Double-Edged Sword in Neural Diseases. Front Cell Neurosci. 2018; 12:206. PMC: 6087757. DOI: 10.3389/fncel.2018.00206. View

17.

Willis E, MacDonald K, Nguyen Q, Garrido A, Gillespie E, Harley S . Repopulating Microglia Promote Brain Repair in an IL-6-Dependent Manner. Cell. 2020; 180(5):833-846.e16. DOI: 10.1016/j.cell.2020.02.013. View

18.

Orellana A, Vasconcelos A, Leite J, de Sa Lima L, Andreotti D, Munhoz C . Age-related neuroinflammation and changes in AKT-GSK-3β and WNT/ β-CATENIN signaling in rat hippocampus. Aging (Albany NY). 2015; 7(12):1094-111. PMC: 4712335. DOI: 10.18632/aging.100853. View

19.

Neal M, Fleming S, Budge K, Boyle A, Kim C, Alam G . Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration. FASEB J. 2020; 34(1):1679-1694. PMC: 7212500. DOI: 10.1096/fj.201900567RR. View

20.

Hagan N, Kane J, Grover D, Woodworth L, Madore C, Saleh J . CSF1R signaling is a regulator of pathogenesis in progressive MS. Cell Death Dis. 2020; 11(10):904. PMC: 7584629. DOI: 10.1038/s41419-020-03084-7. View